Protein Molecule May Improve Survival in Deadly Lung Disease

May 12, 2014, 18:58 PM
announcement_icn_34

New research from the University of Illinois at Chicago College of Medicine, partially funded by the Pulmonary Fibrosis Foundation, finds a protein that seems to slow the progression of pulmonary fibrosis. The finding is reported in the American Journal of Respiratory and Critical Care Medicine.

This paper was co-authored by Dr. Imre Noth, Director of the Interstitial Lung Disease Program at University of Chicago and Dr. Naftali Kaminski, Chief of Pulmonary, Critical Care and Sleep Medicine at Yale University. Dr. Noth and Dr. Kaminski are prominent members of the PFF Medical Advisory Board and both of their ILD programs are involved in the PFF Care Center Network and the PFF Patient Registry.

Posted on:
UIC News
Sharon Parmet
May 6, 2014

Protein Molecule May Improve Survival in Deadly Lung Disease

Researchers at the University of Illinois at Chicago College of Medicine have discovered a protein molecule that seems to slow the progression of pulmonary fibrosis, a progressive lung disease that is often fatal three to five years after diagnosis.

The finding is reported in the American Journal of Respiratory and Critical Care Medicine.

Nearly five million people worldwide are affected by pulmonary fibrosis, which causes the lungs to become covered in fibrous scar tissue and leads to shortness of breath that gets more severe as the disease progresses...

Read More

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >